We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: -0.01 (-1.10%)
Spread: 0.05 (5.747%)
Open: 0.905
High: 0.905
Low: 0.895
Prev. Close: 0.905
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results 2020

26 Nov 2020 10:43

RNS Number : 6289G
JPEL Private Equity Limited
26 November 2020
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

JPEL ANNOUNCES RESULTS OF AGM

 

 

* * *

 

GUERNSEY, 26 NOVEMBER 2020

 

JPEL Private Equity Limited (the "Company") announces that at the Annual General Meeting ("AGM") of the Company held on 25 November 2020, all resolutions put to shareholders at the AGM were duly passed.

 

SUMMARY OF RESOLUTIONS PROPOSED AT AGM

 

SUMMARY OF RESOLUTIONS TO BE PROPOSED

The following summarises all of the resolutions the Company sought approval for at the AGM.

 

Special Resolutions

1. To renew the Company's authority to make purchases of up to 15 per cent. of each class of its own issued Shares pursuant to any proposed Tender Offer.

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of each class of its own issued Shares.

 

Ordinary Resolutions

3. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2020.

4. To re-elect PricewaterhouseCoopers CI LLP as Auditors to the Company.

5. To re-authorise the Directors to determine the Auditors' remuneration.

6. To re-authorise and agree the remuneration of the Directors in accordance with the Articles of Incorporation.

7. To re-elect Christopher P. Spencer as a non-executive, independent director of the Company, who retires by rotation.

8. To re-elect John Loudon as a non-executive, independent director of the Company, who retires by rotation.

9. To re-elect Anthony (Tony) Dalwood as a non-executive, independent director of the Company, who retires by rotation.

10. To re-elect Sean Hurst as a non-executive, independent director of the Company, who retires by rotation.

 

 

 

Below, please find a summary of all votes received for JPEL's AGM:

 

In Favour

Discretion

Against

Withheld

Resolution

Votes

%age

Items

Votes

%age

Items

Votes

%age

Items

Votes

Items

1

87,106,576

100

15

0

0

0

0

0

0

0

0

2

87,106,576

100

15

0

0

0

0

0

0

0

0

3

87,106,576

100

15

0

0

0

0

0

0

0

0

4

87,106,576

100

15

0

0

0

0

0

0

0

0

5

87,106,576

100

15

0

0

0

0

0

0

0

0

6

87,106,576

100

15

0

0

0

0

0

0

0

0

7

76,819,352

88.19

14

0

0

0

10,287,224

11.81

1

0

0

8

59,440,155

68.24

14

0

0

0

27,666,421

31.76

3

0

0

9

87,106,576

100

15

0

0

0

0

0

0

0

0

10

76,819,352

100

14

0

0

0

0

0

0

10,287,224

1

 

 

The Board has considered the results of the AGM today and notes the level of votes cast against resolution 8 (the re-election of John Loudon) by a small number of shareholders.

 

We have engaged with our major shareholders ahead of the vote and understand their views on these matters and the differing philosophies they apply.

 

Following the outcome of today's vote, we will contact shareholders to discuss these matters again and will keep best practice in these areas under review. In accordance with the provisions of the 2019 AIC Code of Corporate Governance, we shall provide an update on this engagement process over the coming months.

 

 

* * *

 

 

 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

 

 

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBGBDBGSDDGGL
Date   Source Headline
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.